Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

(2014) D. Cortinovis et al.   CURRENT PHARMACEUTICAL DESIGN

Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2013) Linda L. Humphrey et al.   ANNALS OF INTERNAL MEDICINE

miRNA-mediated tumor specific delivery of TRAIL reduced glioma growth

(2013) Yongli Bo et al.   JOURNAL OF NEURO-ONCOLOGY

Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells

(2013) Jia Liu et al.   Molecular Oncology

MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met

(2013) Wenting Luo et al.   PLoS One

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6

(2012) Xiaolan Zhu et al.   FEBS LETTERS

Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44+ gastric cancer cells via attenuating Wnt signaling

(2012) Bin Wang et al.   JOURNAL OF GASTROENTEROLOGY

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

(2012) L Y Dimberg et al.   ONCOGENE

MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R

(2012) Biyun Wang et al.   PLoS One

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

(2011) Jean-Charles Soria et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma

(2011) Yasumitsu Moriya et al.   JOURNAL OF HUMAN GENETICS

Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers

(2011) Youguang Zhao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL

(2010) Cigdem Aydin et al.   BMC CANCER

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells.

(2010) Leina Ma et al.   CANCER BIOLOGY & THERAPY

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer

(2010) Jean-Charles Soria et al.   JOURNAL OF CLINICAL ONCOLOGY